![](/img/cover-not-exists.png)
1044PPembrolizumab in patients with MSI-H advanced endometrial cancer from the KEYNOTE-158 study
O'Malley, D, Marabelle, A, De Jesus-Acosta, A, Piha-Paul, S A, Arkhipov, A, Longo, F, Motola-Kuba, D, Shapira-Frommer, R, Geva, R, Rimel, B J, Lopez-Martin, J A, Hansen, A R, Mehnert, J M, Chen, X, JiVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz250.052
Date:
October, 2019
File:
PDF, 95 KB
2019